Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Weidenbach

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Medizinische Klinik|January 9, 1976
[The influence of pregnancy on the venous return from the lower extremities (author's transl)]J Adolf, A Kriessmann, B J Klose, et al.
Geburtshilfe Und Frauenheilkunde|July 1, 1982
[The cardiac hazard of tocolysis and antagonizing possibilities. II. Communication: protection of the myocardium by means of substitution of magnesium]A Wischnik, N Mendler, A Schroll, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1982
[The cardiac hazard of tocolysis and antagonising possibilities. I. The haemodynamic situation of the patient during tocolysis/Protection of the myocardium by means of cardioselective beta-blockade. Experimental results (author's transl)]A Wischnik, N Mendler, W Heimisch, et al.
Medizinische Monatsschrift|February 1, 1977
[Cardiotocographic study of smoking women in pregnancy and during labor]P Krieglsteiner, K Lappy, A Fauner, et al.
Arzneimittel-Forschung|January 1, 1984
[The effect of the beta 1-blocker metoprolol on cyclic 3',5'-adenosine monophosphate in various tissues during long-term tocolysis with fenoterol. Animal experiments on the question of the interactive effects of the principal and adverse effects of beta 2-mimetics with special regard to fetal cardioprotection]A Wischnik, H Hötzinger, B Wischnik, et al.
Medizinische Klinik|October 7, 1977
[Quantitative assessment of drug-induced prophylaxis of postoperative thromboembolism. Comparison of frequencies of deep vein thrombosis and pulmonary embolism using acetylsalicylic-acid, dextran, dihydroergotamine, low-dose heparin and the fixed combination of heparin and dihydroergotamine (author's transl)]G Buttermann, W Theisinger, A Weidenbach, et al.
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: Hemophilia: modified by a post-exercise plasminogen activatorJ W Hampton, A Weidenbach, G E Skye, et al.
Arzneimittel-Forschung|January 1, 1982
[Effect of the combination of the beta-1-blocker metoprolol with the tocolytic fenoterol on uteroplacental hemodynamics and fetal cardiovascular sensitivity with particular consideration of intrauterine fetal malnutrition. Results of animal experiments]A Wischnik, W Heimisch, B Wischnik, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|September 1, 1984
[Clenbuterol and fenoterol--animal experiment comparison of 2 tocolytic agents (with special reference to cardiovascular side effects)]A Wischnik, H Hötzinger, A Schroll, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|November 1, 1982
[Magnesium aspartate as a cardioprotective agent and adjuvant in tocolysis with betamimetics. Animal experiments on the kinetics and calcium antagonist action of orally administered magnesium aspartate with special reference to simultaneous vitamin B administration]A Wischnik, A Schroll, W E Kollmer, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Medizinische Klinik|January 9, 1976
[The influence of pregnancy on the venous return from the lower extremities (author's transl)]J Adolf, A Kriessmann, B J Klose, et al.
Geburtshilfe Und Frauenheilkunde|July 1, 1982
[The cardiac hazard of tocolysis and antagonizing possibilities. II. Communication: protection of the myocardium by means of substitution of magnesium]A Wischnik, N Mendler, A Schroll, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1982
[The cardiac hazard of tocolysis and antagonising possibilities. I. The haemodynamic situation of the patient during tocolysis/Protection of the myocardium by means of cardioselective beta-blockade. Experimental results (author's transl)]A Wischnik, N Mendler, W Heimisch, et al.
Medizinische Monatsschrift|February 1, 1977
[Cardiotocographic study of smoking women in pregnancy and during labor]P Krieglsteiner, K Lappy, A Fauner, et al.
Arzneimittel-Forschung|January 1, 1984
[The effect of the beta 1-blocker metoprolol on cyclic 3',5'-adenosine monophosphate in various tissues during long-term tocolysis with fenoterol. Animal experiments on the question of the interactive effects of the principal and adverse effects of beta 2-mimetics with special regard to fetal cardioprotection]A Wischnik, H Hötzinger, B Wischnik, et al.
Medizinische Klinik|October 7, 1977
[Quantitative assessment of drug-induced prophylaxis of postoperative thromboembolism. Comparison of frequencies of deep vein thrombosis and pulmonary embolism using acetylsalicylic-acid, dextran, dihydroergotamine, low-dose heparin and the fixed combination of heparin and dihydroergotamine (author's transl)]G Buttermann, W Theisinger, A Weidenbach, et al.
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: Hemophilia: modified by a post-exercise plasminogen activatorJ W Hampton, A Weidenbach, G E Skye, et al.
Arzneimittel-Forschung|January 1, 1982
[Effect of the combination of the beta-1-blocker metoprolol with the tocolytic fenoterol on uteroplacental hemodynamics and fetal cardiovascular sensitivity with particular consideration of intrauterine fetal malnutrition. Results of animal experiments]A Wischnik, W Heimisch, B Wischnik, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|September 1, 1984
[Clenbuterol and fenoterol--animal experiment comparison of 2 tocolytic agents (with special reference to cardiovascular side effects)]A Wischnik, H Hötzinger, A Schroll, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|November 1, 1982
[Magnesium aspartate as a cardioprotective agent and adjuvant in tocolysis with betamimetics. Animal experiments on the kinetics and calcium antagonist action of orally administered magnesium aspartate with special reference to simultaneous vitamin B administration]A Wischnik, A Schroll, W E Kollmer, et al.
Pageof 4